Kiora Pharmaceuticals, Inc. Share Price
NASDAQ: KPRX | Micro CapKiora Pharmaceuticals, Inc. Stock Performance
Kiora Pharmaceuticals, Inc. Share Price Today
As of 20 September 2026, Kiora Pharmaceuticals, Inc.'s share price is $2.72. The stock opened at $2.76, compared to its previous close of $2.66. During today's trading session, Kiora Pharmaceuticals, Inc.'s share price traded between $2.72 and $2.78, with an average price of $2.75. Over the past 52 weeks, the stock has recorded a high of $2.89 and a low of $1.82. In terms of performance, Kiora Pharmaceuticals, Inc.'s share price has risen by 43.92% over the last six months and is down 2.51% on a year-on-year basis.
Kiora Pharmaceuticals, Inc. Share Price Chart
Kiora Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Kiora Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, which is in phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; and KIO-101, an eye drop formulation for the treatment of ocular presentation of rheumatoid arthritis. It has strategic development and commercialization agreement with Théa Open Innovation for the development of KIO-301. The company operates in the United States, Austria, and Australia. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.
Kiora Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $2.54 | $2.72 | +3.82% |
Aug 2026 | $2.61 | $2.62 | +5.22% |
Jul 2026 | $2.67 | $2.49 | -4.41% |
Jun 2026 | $2.71 | $2.60 | -4.58% |
May 2026 | $2.40 | $2.73 | +15.68% |
Apr 2026 | $1.90 | $2.36 | +24.87% |
Mar 2026 | $2.02 | $1.89 | -7.35% |
Feb 2026 | $2.40 | $2.04 | -14.47% |
Jan 2026 | $1.99 | $2.38 | +22.31% |
Dec 2025 | $1.92 | $1.95 | +2.63% |
Nov 2025 | $2.42 | $1.90 | -15.56% |
Oct 2025 | $2.87 | $2.25 | -19.35% |
KPRX Share Price FAQs
What is Kiora Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of Kiora Pharmaceuticals, Inc. stock?
What is KPRX's market capitalisation today?
What is KPRX's net income for the last quarter?
What is the 5 year returns of KPRX?
What is the high & low stock price of KPRX today?
Can I buy KPRX shares in India?